Article Details
Retrieved on: 2018-04-29 22:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>La Jolla, California-based Synthorx Inc, a developer of novel protein therapeutics, has raised $63 million in Series C financing. OrbiMed led the round with participation from Medicxi, Osage University Partners, <b>Avalon Ventures</b>, RA Capital Management and Correlation Ventures. In addition to the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here